Back
Speaker illustration

Doctor Paul Michael Haller

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

Member of:

European Society of Cardiology

Dr. Paul Haller earned his MD from the Medical University of Vienna, a doctorate in medicine (Dr. med.) from the Faculty of Medicine at the University of Hamburg, and a PhD in Vascular Biology from the Medical University of Vienna. He is a Fellow in Internal Medicine and Cardiology at the University Heart and Vascular Center Hamburg, and a post-doctoral research fellow at the TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, and a research fellow at Harvard Medical School.

Presentations Articles

Heart failure risk assessment using biomarkers in patients with atrial fibrillation: analysis of 32,041 patients from the COMBINE-AF study

Event: ESC Congress 2024

Topic: Heart Failure in Atrial Fibrillation

Session: The interplay between atrial fibrillation and heart failure: implications for clinicians

Access
Like
Thumbnail

Biomarker-based prediction of fatal and non-fatal cardiovascular outcomes in individuals of the general population with and without diabetes mellitus

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Coronary artery disease - Epidemiology, prognosis, outcome 5

Access
Like
Thumbnail

Characteristics and outcomes of patients with suspected acute myocardial infarction according to rising and falling patterns of high-sensitive cardiac troponin

Event: ESC Congress 2020

Topic: Biomarkers

Session: Acute Coronary Syndromes ePosters

Access
Like
Thumbnail

The association of anemia with high-sensitive cardiac troponin and its influence on the ESC 0/1h and 0/3h algorithms to triage patients with suspected acute myocardial infarction

Event: ESC Congress 2020

Topic: Biomarkers

Session: Acute Coronary Syndromes ePosters

Access
Like
Thumbnail

Performance of the ESC 0/1h- and 0/3h-algorithm for the early diagnosis of myocardial infarction in patients with diabetes mellitus

Event: ESC Congress 2019

Topic: Biomarkers

Session: Cardiac troponins and other biomarkers in acute coronary syndromes

Access
Like
Thumbnail

Changes in extracellular vesicles during and after STEMI and potential influences of remote ischemic conditioning

Event: ESC Congress 2019

Topic: Microvesicles, Exosomes

Session: Extracellular vesicles and cell communication in cardiovascular disease

Access
Like
Thumbnail

The expression of pro-coagulatory endothelial- and monocyte derived extracellular vesicles in patients with coronary artery disease differs depending on the presence of certain cardiovascular risk fac

Event: Frontiers in CardioVascular Biology 2018

Topic: Microvesicles, Exosomes

Session: Extracellular vesicles for cardiovascular repair

Access
Like
Thumbnail

Peak creatine kinase and cardiac troponin I levels and dual time point myocardial SPECT CT

Event: Acute Cardiovascular Care 2018

Topic: Acute Coronary Syndromes: Post-Infarction Period

Session: Biomarkers

Access
Like
Thumbnail

Increased frailty due to myocardial infarction is an independent predictor of long-term survival in patients with acute myocardial infarction

Event: Acute Cardiovascular Care 2018

Topic: Acute Coronary Syndromes – Epidemiology, Prognosis, Outcome

Session: Prognosis

Access
Like
Thumbnail

New frailty assessment based on routine nurse anamnesis before discharge is a strong predictor of all-cause mortality in patients with myocardial infarction

Event: ESC Congress 2017

Topic: Risk scores

Session: Age, elderly and cardiovascular disease

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources